SingaporeOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 4,263 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130,687 | 142,094 |
| Total Cites | 762 | 885 |
| H-index | 14 | 14 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 24 | 25 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 99 | 107 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 694 | 762 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.16 |
| Self-Citation Percentage |
13.90%
|
|
Yoo, Keun Young
Seoul National University College of Medicine,
Korea, Republic of
2023 Rank: 157,636
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 5,618 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157,636 | 150,527 |
| Total Cites | 840 | 984 |
| H-index | 12 | 13 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 20 | 25 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 114 | 124 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 767 | 850 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.16 |
| Self-Citation Percentage |
14.63%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 6,170 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164,045 | 160,364 |
| Total Cites | 809 | 1,008 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 17 | 21 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 95 | 103 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 705 | 809 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.25 |
| Self-Citation Percentage |
19.74%
|
|
Yoo, Keun Young
Seoul National University College of Medicine,
Korea, Republic of
2021 Rank: 113,908
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Epidemiology
Rank in SubField 1: 4,060 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113,908 | 107,802 |
| Total Cites | 1,273 | 1,592 |
| H-index | 15 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 33 | 39 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 162 | 171 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,105 | 1,265 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.26 |
| Self-Citation Percentage |
20.04%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.